Xiaowei Sun
机构：Jiangsu T-mab BioPharma (China), Humanwell Healthcare Group (China), Qilu Hospital of Shandong University · ORCID：0009-0001-3173-7852
发表论文 164 篇 · 总被引 540 次 · h-index 13
代表论文
- Structural basis of nectin-4 recognition by the antibody–drug conjugate 9MW2821 (2025 · Journal of Biological Chemistry · 被引 2)
- Predicting purulent meningitis in very preterm infants: a novel clinical model (2025 · BMC Pediatrics · 被引 2)
- Abstract 830: Combined a B7-H3-targeting antibody-drug conjugate, 7MW3711, and PARP inhibitors synergistically potentiates the antitumor activity in B7-H3-positive cancers (2025 · Cancer Research · 被引 1)
- Supplementary Table S7 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers (2025)
- Supplementary Table S4 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers (2025)
- Supplementary Table S6 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers (2025)